Research library · Health literacy
Why CRP and ESR need not tell the same story
Two tests are often described as inflammatory markers, so it is easy to expect them to move together. When CRP is highlighted and ESR is not, or the reverse happens, a reader may suspect that one result is wrong. But these tests do not measure the same thing.
CRP measures a protein made by the liver in response to inflammation. ESR concerns how quickly red cells settle in a sample. Neither is a direct photograph of an inflamed body part, and neither can identify a disease on its own. Their shared description does not turn them into interchangeable scores.
The MedlinePlus CRP guide explains that a result does not show the cause or location of inflammation. The MedlinePlus ESR guide likewise describes a non-specific test whose interpretation depends on other findings. Knowing their limits is more useful than trying to force agreement between their numbers.
The same label covers different measurements
A hypothetical report contains CRP in one unit and ESR in another. One value is numerically larger. That does not mean the larger number represents more inflammation than the smaller one. The values describe different measurements, so direct subtraction or ranking is meaningless.
The same problem arises when someone puts both into a spreadsheet column called “inflammation”. A graph then suggests that an ESR result can continue a CRP series. It cannot. Keep separate names and units, even if the tests were requested on the same date for related clinical reasons.
ESR can also be influenced by circumstances other than the disease someone is investigating. The MedlinePlus page discusses factors such as age and pregnancy. This does not allow a reader to calculate a personal correction. It explains why a clinician needs context rather than a universal table copied from an online discussion.
Which test answers the clinical question?
A local NHS primary-care guide, Right Test, Right Time, describes CRP as changing earlier and more acutely than ESR and cautions against routinely requesting both without a useful reason. That is guidance for its clinical setting, not a blanket claim that ESR has no role anywhere.
The difference matters to a reader who equates more tests with more certainty. An additional measurement may add relevant information, but that depends on the investigation. Asking what the second test would contribute is sensible; insisting on both because they share a label does not establish that benefit.
A hypothetical clinician is following a specific condition using a chosen marker. A different clinician is investigating a new symptom. Even if both request something called an inflammatory marker, their reasons may differ. The fact that your friend's panel contains ESR while yours contains CRP is not evidence that one panel is incomplete.
Another naming detail deserves attention: high-sensitivity CRP, often written hs-CRP, is not simply a premium version to substitute into any discussion. MedlinePlus describes its use in a different context, including cardiovascular risk assessment. Keep the exact test name when saving a report, rather than deleting the prefix.
A disagreement is a question to explain
If the two results seem inconsistent, a useful appointment question is: “Were these tests expected to add different information, and how does their timing affect this investigation?” This is better than asking which one is the true inflammation score. It allows the clinician to discuss the actual reason for requesting them.
Bring the dates, units and relevant symptoms with the complete report. Avoid converting symptoms into a number or dismissing them because one marker is unflagged. These sources do not show that a single in-range inflammatory marker excludes every inflammatory condition.
Do not start an “anti-inflammatory” supplement plan to lower a laboratory number without clinical advice. A change in a marker is not automatically proof that a consumer product treated the cause, and the sources here do not test such a product.
Your next practical step is to check whether your report says CRP, hs-CRP or ESR, then ask what that particular measurement contributes to the question being investigated. Keep it attached to that question rather than treating it as a general health grade.
The DomDNA quiz offers separate lifestyle education. It performs no DNA analysis and cannot interpret inflammatory markers or diagnose their cause.
Draft • Research checked 4 October 2026 • AI-assisted DomDNA editorial content. No independent clinical review or publication is claimed. General education, not individual medical advice.
Original source and access ledger
- C-reactive protein test
sourceDate: 2025-06-11
type: Official NLM patient education
population: People undergoing CRP investigation
endpoint: Protein measurement and non-specificity
supportedClaimAndLimit: CRP alone does not identify the cause or location; hs-CRP has different clinical uses.
fundingAndConflicts: Official or institutional educational resource; not a commercial efficacy trial. Complete contributor disclosures not audited.
accessEvidence: Official page text opened via web. Access checked via web on 2026-10-04.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive retraction, correction or guideline-surveillance claim.
sourceWordLimit: 200
quoteWords: 0
sourceUseBudget: 200-word maximum across article, social adaptations, script and ledger for this source; no verbatim quotations. Claims kept narrow; original hypothetical examples and communication suggestions are not research findings.
- Erythrocyte sedimentation rate
sourceDate: 2024-12-02
type: Official NLM patient education
population: People undergoing ESR investigation
endpoint: Red-cell settling and contextual influences
supportedClaimAndLimit: ESR measures settling, is non-specific and cannot exclude every inflammatory condition when unflagged.
fundingAndConflicts: Official or institutional educational resource; not a commercial efficacy trial. Complete contributor disclosures not audited.
accessEvidence: Official page text opened via web. Access checked via web on 2026-10-04.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive retraction, correction or guideline-surveillance claim.
sourceWordLimit: 200
quoteWords: 0
sourceUseBudget: 200-word maximum across article, social adaptations, script and ledger for this source; no verbatim quotations. Claims kept narrow; original hypothetical examples and communication suggestions are not research findings.
- Right Test, Right Time
sourceDate: Page date not established; checked 2026-10-04
type: Official local NHS ICB clinical guidance
population: Primary-care users of the local guidance
endpoint: CRP timing and appropriate paired testing
supportedClaimAndLimit: Local guide discusses earlier CRP changes and discourages routine paired testing without benefit. Not a universal ban on ESR.
fundingAndConflicts: Official or institutional educational resource; not a commercial efficacy trial. Complete contributor disclosures not audited.
accessEvidence: Official West and North London ICB page opened; local primary-care scope retained. Access checked via web on 2026-10-04.
researchDate: 2026-10-04
correctionStatus: Access-date source check only; no comprehensive retraction, correction or guideline-surveillance claim.
sourceWordLimit: 200
quoteWords: 0
sourceUseBudget: 200-word maximum across article, social adaptations, script and ledger for this source; no verbatim quotations. Claims kept narrow; original hypothetical examples and communication suggestions are not research findings.
Download exact original article Markdown · Download exact source and unsent social pack
Finished companion media
Silent films, slides and source captions on the separate dashboard. Original preview and historical product limits remain in their captions. No social campaign has been sent.